Fierce Biotech1 min read
saveAbbVie busts a move with Disco in $2.5B dance aimed at bispecific discovery
AbbVie is twirling onto the dance floor with Disco Pharmaceuticals, offering up to $2.5 billion to work with the German platform company on cancer-targeted bispecific discovery.
comments(0)
5-min edit window · permanent after that